Results 231 to 240 of about 81,715,714 (308)

Multicenter Renal Pharmacist Group-Pharmaceutical Care for Patients with Renal Impairment at Four Non-University Hospitals in Germany. [PDF]

J Clin Med
Seiberth S, Bayerlein K, Gerke AK, Ihbe-Heffinger A, Schobel HP, Rudolph J, Leuschner S, Müller P, Richling I, Owandner B, Schmidt-Schnaubelt T, Sieg M, Albus L, von Ameln-Mayerhofer A, Strobach D.   +14 more
europepmc   +1 more source

THE UNIVERSITY HOSPITAL SHOULDER SPLINT

Annals of Surgery, 1917
openaire   +3 more sources

Evaluation of Digital Technologies for Home‐Based Assessment in People With Amyotrophic Lateral Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Digital technologies hold promise for transforming healthcare by enhancing personalized treatments and offer valuable opportunities to improve patient care. Here, we evaluated several novel, self‐administered, home‐based, digital endpoints for their association with corresponding conventional standard clinical measures (primary) in ...
Arne Mueller, Vanessa Vallejo, Mónica Povedano Panadés, Orla Hardiman, Véronique Danel‐Brunaud, Senda Ajroud‐Driss, Philippe Couratier, Jeremy Shefner, Anna Gokey, Mike DiCesare, Erin Lennox, Jens Praestgaard, Lucie Brujin, Peggy Allred, Ram Miller   +14 more
wiley   +1 more source

Wish to die trying to live: unwise or incapacitous? The case of University Hospitals Birmingham NHS Foundation Trust versus 'ST'. [PDF]

J Med Ethics
Wellesley J, Wilkinson D, Moore B.
europepmc   +1 more source

Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit, Chiranth K. Nagaraj, Jackson S. Newell, Kim Truc Nguyen, Xilal Y. Rima, Jacob Doon‐Ralls, Eduardo Reátegui, Jeffrey M. Statland, Rabi Tawil, Kevin M. Flanigan, Scott Q. Harper, Nizar Y. Saad   +11 more
wiley   +1 more source

Comparison of Commercial Lateral Flow Immunochromatography with Phenotypic and Genotypic Assays for the Detection of Carbapenemase-Producing Gram-Negative Bacteria at Tanta University Hospitals. [PDF]

Microorganisms
Taha MS, Gabr BM, Elaziz WA, Elgohary AM, Kasem BS, Elkolaly RM, Elatrozy HIS, Emam MN, Essawy AS, Eldin HEMS, Mohamed RA, Elkadeem MZ, Abdelbaky S, Gadallah MAE.   +13 more
europepmc   +1 more source

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito, Kamal Benguerba, Ken Tsuchida, Kazushige Yazawa, Isao Tsumiyama, Hiromitsu Kayama, Sandra P. Reyna, Farid Khan, Richard S. Finkel   +8 more
wiley   +1 more source

Correction: A nationwide questionnaire survey to investigate facility‑based disparities in satisfaction and working conditions of surgical trainees in Japan: university hospitals, community hospitals, and hybrid‑type facilities. [PDF]

Surg Today
Koike D, Takagi K, Arai K, Kiyasu Y, Kohmura T, Suda C, Takamori S, Takayama W, Nakamura M, Fukumoto M, Yamaoka-Fujikawa Y, Watanabe G, Watanabe J, Poudel S, Ikeda N, Taketomi A, Saito M.   +16 more
europepmc   +1 more source

Uncovering G Protein‐Coupled Receptors: Novel Targets and Biomarkers for Predicting Glioma Prognosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Low‐grade gliomas (LGG) exhibit significant heterogeneity and recurrence risk. G protein‐coupled receptors (GPCR) contribute to glioma malignant progression, but their prognostic value remains unclear. This work attempts to formulate a GPCR‐based outcome‐predicting model for LGG. Methods Based on TCGA LGG data, the enrichment scores
Jun Yang, Dongxu Zhang, Dongyuan Liu, Da Lin, Hao Wang   +4 more
wiley   +1 more source